← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 27, 2019Last known activity
Dec 30, 2025
Timeline
2010s
- Jan 1, 2017
Elixiron Immunotherapeutics Inc.— Founded
Drugs by trial phase (2 distinct, 4 trials)
Recent trials (4)
- NCT07223229Lead sponsorPhase 2Dec 30, 2025
- NCT06745583Lead sponsorPhase 2Dec 31, 2024
- NCT04994912Lead sponsorPhase 1Oct 31, 2021
- NCT04238364Lead sponsorPhase 1Dec 27, 2019
Details
- Founded
- Taipei, TW Jan 1, 2017
- Last known activity
- Dec 30, 2025